| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement of reviewers 2017
|
|
|
2018
|
82 |
6 |
p. 1089-1092
|
artikel
|
| 2 |
A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients
|
Hamaguchi, Tetsuya
|
|
2018
|
82 |
6 |
p. 1021-1029
|
artikel
|
| 3 |
A phase II trial of EGFR-TKI readministration with afatinib in advanced non-small-cell lung cancer harboring a sensitive non-T790M EGFR mutation: Okayama Lung Cancer Study Group trial 1403
|
Oda, Naohiro
|
|
2018
|
82 |
6 |
p. 1031-1038
|
artikel
|
| 4 |
Autophagy modulation: a prudent approach in cancer treatment?
|
Bishop, Eleanor
|
|
2018
|
82 |
6 |
p. 913-922
|
artikel
|
| 5 |
Autophagy therapeutics: preclinical basis and initial clinical studies
|
Zhan, Lei
|
|
2018
|
82 |
6 |
p. 923-934
|
artikel
|
| 6 |
Comment on: Yohshino et al.: combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6). Cancer Chemother Pharmacol (2017) 80:1239–1247
|
Eichbaum, Michael
|
|
2018
|
82 |
6 |
p. 1087-1088
|
artikel
|
| 7 |
Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells
|
Cao, Yong
|
|
2018
|
82 |
6 |
p. 1081-1086
|
artikel
|
| 8 |
Exposure–response analysis and simulation of lenvatinib safety and efficacy in patients with radioiodine-refractory differentiated thyroid cancer
|
Hayato, Seiichi
|
|
2018
|
82 |
6 |
p. 971-978
|
artikel
|
| 9 |
FOXC2 promotes epithelial–mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells
|
He, Yuwen
|
|
2018
|
82 |
6 |
p. 1049-1059
|
artikel
|
| 10 |
Lactobacillus supplementation prevents cisplatin-induced cardiotoxicity possibly by inflammation inhibition
|
Zhao, Lianbi
|
|
2018
|
82 |
6 |
p. 999-1008
|
artikel
|
| 11 |
No significant impact of patient age and prior treatment profile with docetaxel on the efficacy of cabazitaxel in patient with castration-resistant prostate cancer
|
Kosaka, Takeo
|
|
2018
|
82 |
6 |
p. 1061-1066
|
artikel
|
| 12 |
Oleandrin synergizes with cisplatin in human osteosarcoma cells by enhancing cell apoptosis through activation of the p38 MAPK signaling pathway
|
Yong, Lei
|
|
2018
|
82 |
6 |
p. 1009-1020
|
artikel
|
| 13 |
Oncogenic roles of serine–threonine kinase receptor-associated protein (STRAP) in osteosarcoma
|
Pruksakorn, Dumnoensun
|
|
2018
|
82 |
6 |
p. 1039-1047
|
artikel
|
| 14 |
Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine–erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)
|
Maurel, Joan
|
|
2018
|
82 |
6 |
p. 935-943
|
artikel
|
| 15 |
Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-KrasG12D/+;Tp53R172H/+ (KPC) mice, a genetically engineered model of pancreatic cancer
|
Vilimas, Tomas
|
|
2018
|
82 |
6 |
p. 1067-1080
|
artikel
|
| 16 |
Phase I trial of afatinib and 3-weekly trastuzumab with optimal anti-diarrheal management in patients with HER2-positive metastatic cancer
|
Martin, Nicolas
|
|
2018
|
82 |
6 |
p. 979-986
|
artikel
|
| 17 |
Relationship between folate concentration and expression of folate-associated genes in tissue and plasma after intraoperative administration of leucovorin in patients with colorectal cancer
|
Taflin, Helena
|
|
2018
|
82 |
6 |
p. 987-997
|
artikel
|
| 18 |
Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancer
|
Mayer, Robert J.
|
|
2018
|
82 |
6 |
p. 961-969
|
artikel
|
| 19 |
Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma
|
Das, Arabinda
|
|
2018
|
82 |
6 |
p. 945-952
|
artikel
|
| 20 |
The maximum chemiluminescence intensity predicts severe neutropenia in gemcitabine-treated patients with pancreatic or biliary tract cancer
|
Goto, Koki
|
|
2018
|
82 |
6 |
p. 953-960
|
artikel
|
Tijdschrift beschrijving